Postmenopausal Vaginal Atrophy and Atrophic Vaginitis

This publication has 18 references indexed in Scilit:

• Estradiol delivery by vaginal rings: potential for hormone replacement therapy
  Maturitas, 1997
• Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
• A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging
  American Journal of Obstetrics and Gynecology, 1996
• A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy
  American Journal of Obstetrics and Gynecology, 1994
• Low-dose 17β-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
• Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study
  Maturitas, 1992
• Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets
  Maturitas, 1991
• Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women
  Maturitas, 1991
• Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones
  JAMA, 1983
• Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women
  Maturitas, 1981